Purpose: As some surgical procedures have been shown to increase postoperative flare values and thus contribute to blood-ocular barrier breakdown, retinal reattachment surgery might influence the risk of developing proliferative vitreoretinopathy (PVR). Therefore, we investigated whether postoperative aqueous flare values are a surrogate marker for the development of postoperative PVR. Methods: We prospectively included 195 patients with primary rhegmatogenous retinal detachment (RRD) and measured aqueous laser flare preoperatively, and at 2 and 6 weeks postoperatively. Postoperative PVR was defined as reoperation for redetachment due to PVR membranes, within 6 months of initial surgery. Logistic regression and receiver operating characteristic (ROC) analysis determined whether higher postoperative flare values were associated with an increased risk of developing PVR later on. Results: Reoperation for postoperative PVR was needed in 12 (6.2%) patients; in 18 (9.2%), reoperation was not related to PVR. The median flare value for patients who would develop PVR was significantly higher than that of patients who would not develop PVR, both at 2 weeks (p = 0.001) and 6 weeks (p < 0.001) postoperatively. Logistic regression analyses showed that a higher flare value significantly increased the odds of developing PVR, either at 2 weeks [odds ratio (OR) 1.027; 95% CI: 1.010-1.044] or 6 weeks (OR 1.076; 95% CI: 1.038-1.115). Conclusion: Flare values both at 2 and 6 weeks postoperatively seem a good surrogate marker in terms of sensitivity and specificity for the development of postoperative PVR but have only a modest positive predictive value. The 2-week value would be more useful in terms of early recognition of high-risk patients and hence give the possibility to better study effects of treatment methods.
Introduction
Anterior chamber aqueous flare -a surrogate marker for inflammationhas been proposed as a predictor for PVR in patients with a RRD (Schroder et al. 2012; Hoerster et al. 2013; Conart et al. 2017) . In contrast to previous reports, we recently reported that the preoperative aqueous flare value is not a strong predictor for the development of PVR postoperatively (Mulder et al. 2017) .
Although a minority of patients without a history of ocular disease presents with PVR prior to retinal reattachment surgery, in industrialized countries, 5-10% of patients typically develop PVR in 2 weeks to 6 months after surgery. Some of these surgical procedures have been shown to increase postoperative flare values and thus contribute to blood-ocular barrier breakdown (Veckeneer et al. 2001; Jumper et al. 2006; Bali et al. 2010; Hoshi et al. 2012) . Therefore, retinal reattachment surgery is thought to possibly influence the risk of developing postoperative PVR (Cowley et al. 1989) .
The flare value after surgery might, therefore, be a better indication of the development of postoperative PVR than the preoperative flare value. We investigated whether postoperative aqueous flare values or a change in aqueous flare values from preoperative to postoperative are a surrogate marker for the development of postoperative PVR.
Patients and Methods

Patients
From January 2014 until October 2014, we included 208 patients with RRD admitted to the Rotterdam Eye Hospital, the Netherlands. Patients with additional ocular pathologies such as active uveitis, active vasculitis, retinal vein occlusion, diabetic macular oedema, proliferative diabetic retinopathy, exudative age-related macular degeneration and primary PVR grade C or higher were excluded. Postoperative PVR was defined as reoperation for redetachment due to PVR membranes, within 6 months of initial surgery. This information was extracted from the patient's file or, when not conclusive, by contacting either the patient or his/her current physician. The standardized surgical reports of the reoperations and the patient's file were evaluated by one vitreoretinal surgeon (masked to flare values) who scored each reoperation as either not PVR related or PVR related.
The study followed the tenets of the Declaration of Helsinki and was approved by the institutional review board. All patients gave written informed consent. This patient cohort has been part of a previously published report with a different research question exclusively on preoperative measurements (Mulder et al. 2017 ).
Flare measurements
Aqueous laser flare of the anterior chamber was measured preoperatively and during regular postoperative visits at 2 and 6 weeks with a Kowa FM-500 Laser Flare Meter (Kowa Company Ltd. Tokyo, Japan). We performed seven measurements 15 min after instillation of 0.5% tropicamide eye drops. The highest and the lowest value were discarded, leaving an average of five measurements. (Shah et al. 1991; Veckeneer et al. 2001; Bali et al. 2010) . For the purpose of the sample size calculation of the original study (Mulder et al. 2017) , it was assumed that the standard deviation (SD) would be slightly higher (SD = 0.4). The incidence of PVR was estimated at 10%, the two-sided significance level was set at a = 0.05, power at p = 0.80 and a factor two increase in flare value was thought to be clinically relevant. This led to a sample size of 176 eyes, of which at least 16 eyes were expected to develop postoperative PVR.
Statistical analysis
As aqueous flare values are not normally distributed, we looked at median flare values and used non-parametric tests. Patients who required reoperation for another indication than PVR were displayed as a separate group but for the logistic regression and ROC analysis they were included in the uncomplicated RRD group. Median flare values of the three groups were compared using a Kruskal-Wallis test with pairwise comparisons for both time-points (2 and 6 weeks).
We performed logistic regression to assess to what extent a higher postoperative flare value at either 2 or 6 weeks increased the risk of postoperative PVR development. Receiver operating characteristic (ROC) analysis was used to test the sensitivity and specificity of postoperative flare values in discriminating between PVR and no PVR development and to define the optimal cut-off point. A MannWhitney U-test was used to compare the individual changes in flare values from preoperative to 2 weeks postoperatively between the two groups.
Statistical analyses were performed with IBM SPSS statistics version 21 (IBM Corp., Armonk, NY, USA).
Results
We included 208 patients, of which five patients were excluded due to other ocular pathology than RRD, three had preoperative PVR, two patients were lost to follow-up, two had multiple failed flare measurements and one received only laser treatment. The characteristics of the remaining 195 patients are shown in Table 1 . Thirty patients (15%) underwent reoperation, out of whom four patients had a persistent detachment (reoperation within 1 week) and 12 patients (6.2%) developed postoperative PVR, for which surgery was performed. The remaining 14 patients had redetachments caused by new breaks (n = 8), not completely closed old breaks (n = 4), a macular hole (n = 1) or giant tear (n = 1), without any signs of traction due to epiretinal membranes or subretinal strands. The median time until reoperation was 49 days (range 12-183 days) for patients who had developed PVR and 20 days (range 2-139 days) for reoperation due to other reasons.
Postoperative flare values
At 2 weeks postoperatively, the pairwise comparisons showed a significant difference between patients who would develop PVR postoperatively and patients with uncomplicated RRD (adjusted p = 0.001; n = 10 versus n = 162). The median flare value of patients with a reoperation due to other reasons (n = 12) did not differ significantly from the two other groups (adjusted p = 0.526 and p = 0.176), at 2 weeks postoperatively. At 6 weeks, the flare values of patients who would develop PVR (n = 8) remained higher than those of patients who received a reoperation for another reason (adjusted p = 0.002; n = 5) and of patients with uncomplicated RRD (adjusted p < 0.001; n = 164).
As eight patients required reoperation before their evaluation visit at 2 weeks and nine patients required reoperation before their evaluation visit at 6 weeks, the flare values of those visits are missing. Figure 1 shows the median flare values overtime for the three mentioned groups. The whiskers represent the interquartile ranges.
Postoperative flare value and risk of PVR development
We tested whether a higher flare value at either 2 or 6 weeks after surgery was a surrogate marker for a future PVR redetachment. Patients requiring reoperation due to other reasons than PVR were included in the uncomplicated group. The logistic regression analysis showed a significant result for both time-points (see Table 2 ).
Sensitivity, specificity and positive predictive value
The ROC analysis showed high area under the ROC curves for both the 2-week postoperative values (0.84; 95% CI: 0.76-0.93) and the 6-week postoperative values (0.92; 95% CI: 0.86-0.97). A cut-off value of 34 pc/ms 2 weeks postoperatively led to both a sensitivity and specificity of 80% (see Fig. 2 ). For the values obtained at 6 weeks, the optimal cut-off value was 27 pc/ms, with an accompanying sensitivity and specificity of 100% and 83%. A cut-off of 27 pc/ms for the 2-week postoperative values showed 85% sensitivity and 69% specificity. The probability that a patient with a flare value above 27 pc/ms at 2 or 6 weeks postoperatively developed a PVR redetachment -the positive predictive value -was 14.5 and 22%. The positive predictive value with a cut-off of 34 pc/ms 2 weeks postoperatively was 18%.
Absolute change in flare values from preoperatively to 2 weeks postoperatively We calculated the individual absolute change in pc/ms from the preoperative value to the 2-week flare value for patients who would not develop PVR (uncomplicated RRD) -including patients with reoperations due to other reasons-and for patients who would later develop postoperative PVR. A positive value in Fig. 3 means that the flare value increased after surgery, and a negative value means a decrease in flare value. Figure 3 shows that the flare value in patients who would later develop postoperative PVR increased in half of the patients and decreased in the other half. In patients who would not develop PVR, the flare value increased slightly in most cases. The distribution of differences was not significantly different between the two groups (Mann-Whitney U-test p = 0.672). One factor that potentially could contribute to a large drop in the flare value postoperatively is the reversal of hypotony. Three patients presented with an intraocular pressure (IOP) ≤4 mmHg preoperatively, of which one developed PVR. In this patient, the flare value changed from 43 pc/ms preoperatively to 37 pc/ms 2 weeks postoperatively.
Discussion
The logistic regression analysis showed that a higher postoperative flare value at either 2 or 6 weeks increased the chance of developing postoperative PVR ( Table 2 ). The ROC analysis provided insight into the optimal cutoff values, which is a balance between not missing any patients who will develop postoperative PVR (sensitivity) and not labelling too many Primary success, n (%) 165 (85) Persistent detachment, n (%) 4 (2.1) CE = cataract extraction, IOP = intraocular pressure, PPV = pars plana vitrectomy, PVR = proliferative vitreoretinopathy, RRD = rhegmatogenous retinal detachment, SD = standard deviation. patients incorrectly as high-risk patients (specificity). The area under the ROC curve showed a better result for the 6-week values, due to reaching 100% sensitivity and a good specificity. The accompanying cut-off value was 27 pc/ms. None of the eight patients who had not yet developed postoperative PVR at that point had a flare value below this value, and 28 out of 183 patients who would not develop PVR had a flare value above 27 pc/ms (specificity 83%). For the 2-week values, the optimum was 80% sensitivity with 80% specificity and an accompanying cut-off value of 34 pc/ms. Although the ROC analyses showed high sensitivity and specificity at a cutoff value of 34 pc/ms and 27 pc/ms at 2 and 6 weeks postoperatively, this led to positive predictive values of only 18% and 22%. The main reason for this was the low prevalence of postoperative PVR in our study (6.2%). Previously, we concluded that preoperative flare values are inaccurate in discriminating between high and low risk of developing PVR. While the logistic regression analysis showed a statistically significant value (p = 0.005), the accompanying OR was low (1.014) and at a cut-off value of 15 pc/ms, the low sensitivity (50%), specificity (76%) led to a positive predictive value of only 12% (Mulder et al. 2017 ). The choice of using a test with a relatively low positive predictive value and thus a high false discovery rate depends on the consequences and risks for the patient associated with a positive test, such as possible side-effects of the treatment initiated. However, the use of postoperative flare would improve the selection of patients by three times relative to the prevalence in our unselected cohort and would miss fewer patients that would later develop PVR than when using the preoperative value. In a new study design, this could be of value to improve the ratio between cases and controls.
Although the 6-week measurements proved to be a better marker for later PVR than the 2-week measurements, the 2-week measurements would be more useful in terms of earlier recognition of high risk for PVR and subsequently the possibility to start a treatment. Moreover, at 2 weeks fewer patients will have already experienced a PVR redetachment. Postoperative therapeutic options would be the administration of oral drugs or injections when such a treatment would be available and effective (Fekrat et al. 1995; Jonas et al. 2003; Ahmadieh et al. 2008 Ahmadieh et al. , 2015 Chang et al. 2008; Koerner et al. 2012; Mulder et al. 2016) . Both postoperative measurements could be used by ophthalmologists to monitor 3 . Histogram of absolute differences between the preoperative value and postoperative value at 2 weeks. A positive value means an increase after surgery; a negative value, a decrease after surgery. PVR = proliferative vitreo retinopathy, RRD = rhegmatogenous retinal detachment. inflammation and study treatment methods. The absolute flare value was a better surrogate marker for postoperative PVR development than the change in flare value. While the overall trend in flare values was an increase after surgery followed by a decrease towards 6 weeks, the individual changes from the preoperative flare value to the postoperative flare value at 2 weeks did not show a clear trend. This was highlighted in the ten patients who would later develop PVR: flare values increased in five cases but decreased in the five other cases.
The absence of a clear trend might be the result of specific proceedings and choices by the surgeon and/or patient during surgery and the early postoperative phase. Patients who underwent a vitrectomy procedure seemed to have higher postoperative flare values than patients who underwent scleral buckling, independent of the number of quadrants detachment (data not shown). In addition, factors such as the occurrence of complications, duration of surgery, choice of vital dyes, manipulation due to indentation and the use of antibiotics and/or steroids may influence the inflammatory response. Figuring out the individual importance of these factors would require an extremely large sample size, whereas the postoperative flare value represents the sum of these factors.
Adding the outcome of postoperative aqueous flare measurements to existing risk prediction models could possibly increase its value. The size of a detachment is a well-known risk factor for the development of PVR, but the size of the detachment is also correlated with flare (Schroder et al. 2012; Conart et al. 2017 ). In our study, this association was the strongest for preoperative flare and higher number of quadrants detachment (r s = 0.42, p < 0.001), and for postoperative flare, this association was weak (r s = 0.20, p = 0.005). In addition, correcting for the number of quadrants detachment in the logistic regression analysis did not change the OR for the postoperative flare value (data not shown).
These results should, however, be interpreted with caution due to a lower prevalence of postoperative PVR in our sample than anticipated. In conclusion, postoperative flare values 2 weeks after RRD surgery are a reasonable surrogate marker for the development of postoperative PVR. These results should be validated in other cohorts including more patients with postoperative PVR.
